Report Detail
Global Atovaquone and Proguanil Market Insights, Forecast to 2025
- RnM3521247 |
- 14 June, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
The global Atovaquone and Proguanil market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Atovaquone and Proguanil market based on company, product type, end user and key regions.
This report studies the global market size of Atovaquone and Proguanil in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Atovaquone and Proguanil in these regions.
This research report categorizes the global Atovaquone and Proguanil market by top players/brands, region, type and end user. This report also studies the global Atovaquone and Proguanil market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Market size by Product
250 mg/100 mg
62.5mg/25mg
Market size by End User
Adult
Paediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Atovaquone and Proguanil market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Atovaquone and Proguanil market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Atovaquone and Proguanil companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Atovaquone and Proguanil submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Atovaquone and Proguanil are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Atovaquone and Proguanil market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Atovaquone and Proguanil Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Atovaquone and Proguanil Market Size Growth Rate by Product
- 1.4.2 250 mg/100 mg
- 1.4.3 62.5mg/25mg
- 1.5 Market by End User
- 1.5.1 Global Atovaquone and Proguanil Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Paediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Atovaquone and Proguanil Market Size
- 2.1.1 Global Atovaquone and Proguanil Revenue 2014-2025
- 2.1.2 Global Atovaquone and Proguanil Sales 2014-2025
- 2.2 Atovaquone and Proguanil Growth Rate by Regions
- 2.2.1 Global Atovaquone and Proguanil Sales by Regions
- 2.2.2 Global Atovaquone and Proguanil Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Atovaquone and Proguanil Sales by Manufacturers
- 3.1.1 Atovaquone and Proguanil Sales by Manufacturers
- 3.1.2 Atovaquone and Proguanil Sales Market Share by Manufacturers
- 3.1.3 Global Atovaquone and Proguanil Market Concentration Ratio (CR5 and HHI)
- 3.2 Atovaquone and Proguanil Revenue by Manufacturers
- 3.2.1 Atovaquone and Proguanil Revenue by Manufacturers (2014-2019)
- 3.2.2 Atovaquone and Proguanil Revenue Share by Manufacturers (2014-2019)
- 3.3 Atovaquone and Proguanil Price by Manufacturers
- 3.4 Atovaquone and Proguanil Manufacturing Base Distribution, Product Types
- 3.4.1 Atovaquone and Proguanil Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Atovaquone and Proguanil Product Type
- 3.4.3 Date of International Manufacturers Enter into Atovaquone and Proguanil Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Atovaquone and Proguanil Sales by Product
- 4.2 Global Atovaquone and Proguanil Revenue by Product
- 4.3 Atovaquone and Proguanil Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Atovaquone and Proguanil Breakdown Data by End User
6 North America
- 6.1 North America Atovaquone and Proguanil by Countries
- 6.1.1 North America Atovaquone and Proguanil Sales by Countries
- 6.1.2 North America Atovaquone and Proguanil Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Atovaquone and Proguanil by Product
- 6.3 North America Atovaquone and Proguanil by End User
7 Europe
- 7.1 Europe Atovaquone and Proguanil by Countries
- 7.1.1 Europe Atovaquone and Proguanil Sales by Countries
- 7.1.2 Europe Atovaquone and Proguanil Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Atovaquone and Proguanil by Product
- 7.3 Europe Atovaquone and Proguanil by End User
8 Asia Pacific
- 8.1 Asia Pacific Atovaquone and Proguanil by Countries
- 8.1.1 Asia Pacific Atovaquone and Proguanil Sales by Countries
- 8.1.2 Asia Pacific Atovaquone and Proguanil Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Atovaquone and Proguanil by Product
- 8.3 Asia Pacific Atovaquone and Proguanil by End User
9 Central & South America
- 9.1 Central & South America Atovaquone and Proguanil by Countries
- 9.1.1 Central & South America Atovaquone and Proguanil Sales by Countries
- 9.1.2 Central & South America Atovaquone and Proguanil Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Atovaquone and Proguanil by Product
- 9.3 Central & South America Atovaquone and Proguanil by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Atovaquone and Proguanil by Countries
- 10.1.1 Middle East and Africa Atovaquone and Proguanil Sales by Countries
- 10.1.2 Middle East and Africa Atovaquone and Proguanil Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Atovaquone and Proguanil by Product
- 10.3 Middle East and Africa Atovaquone and Proguanil by End User
11 Company Profiles
- 11.1 GSK
- 11.1.1 GSK Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GSK Atovaquone and Proguanil Products Offered
- 11.1.5 GSK Recent Development
- 11.2 Glenmark
- 11.2.1 Glenmark Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Glenmark Atovaquone and Proguanil Products Offered
- 11.2.5 Glenmark Recent Development
- 11.3 Mylan Pharmaceuticals
- 11.3.1 Mylan Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Products Offered
- 11.3.5 Mylan Pharmaceuticals Recent Development
- 11.4 Hetero
- 11.4.1 Hetero Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Hetero Atovaquone and Proguanil Products Offered
- 11.4.5 Hetero Recent Development
12 Future Forecast
- 12.1 Atovaquone and Proguanil Market Forecast by Regions
- 12.1.1 Global Atovaquone and Proguanil Sales Forecast by Regions 2019-2025
- 12.1.2 Global Atovaquone and Proguanil Revenue Forecast by Regions 2019-2025
- 12.2 Atovaquone and Proguanil Market Forecast by Product
- 12.2.1 Global Atovaquone and Proguanil Sales Forecast by Product 2019-2025
- 12.2.2 Global Atovaquone and Proguanil Revenue Forecast by Product 2019-2025
- 12.3 Atovaquone and Proguanil Market Forecast by End User
- 12.4 North America Atovaquone and Proguanil Forecast
- 12.5 Europe Atovaquone and Proguanil Forecast
- 12.6 Asia Pacific Atovaquone and Proguanil Forecast
- 12.7 Central & South America Atovaquone and Proguanil Forecast
- 12.8 Middle East and Africa Atovaquone and Proguanil Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Atovaquone and Proguanil Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Atovaquone and Proguanil. Industry analysis & Market Report on Atovaquone and Proguanil is a syndicated market report, published as Global Atovaquone and Proguanil Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Atovaquone and Proguanil market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
